Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA LUPIN AJANTA PHARMA/
LUPIN
 
P/E (TTM) x 25.3 415.8 6.1% View Chart
P/BV x 4.8 2.9 162.7% View Chart
Dividend Yield % 0.8 0.5 151.1%  

Financials

 AJANTA PHARMA   LUPIN
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
LUPIN
Mar-22
AJANTA PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs1,6141,268 127.4%   
Low Rs1,089679 160.4%   
Sales per share (Unadj.) Rs391.1361.0 108.4%  
Earnings per share (Unadj.) Rs83.4-33.2 -251.2%  
Cash flow per share (Unadj.) Rs98.13.3 2,992.4%  
Dividends per share (Unadj.) Rs9.504.00 237.5%  
Avg Dividend yield %0.70.4 171.0%  
Book value per share (Unadj.) Rs382.1263.9 144.8%  
Shares outstanding (eoy) m85.42454.48 18.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.52.7 128.2%   
Avg P/E ratio x16.2-29.3 -55.3%  
P/CF ratio (eoy) x13.8296.8 4.6%  
Price / Book Value ratio x3.53.7 95.9%  
Dividend payout %11.4-12.0 -94.6%   
Avg Mkt Cap Rs m115,433442,238 26.1%   
No. of employees `000NANA-   
Total wages/salary Rs m6,45829,893 21.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,410164,055 20.4%  
Other income Rs m1,1572,137 54.1%   
Total revenues Rs m34,567166,192 20.8%   
Gross profit Rs m9,2932,152 431.7%  
Depreciation Rs m1,25316,587 7.6%   
Interest Rs m1021,428 7.1%   
Profit before tax Rs m9,095-13,726 -66.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9681,372 143.5%   
Profit after tax Rs m7,127-15,097 -47.2%  
Gross profit margin %27.81.3 2,120.0%  
Effective tax rate %21.6-10.0 -216.6%   
Net profit margin %21.3-9.2 -231.8%  
BALANCE SHEET DATA
Current assets Rs m24,548124,577 19.7%   
Current liabilities Rs m8,37782,764 10.1%   
Net working cap to sales %48.425.5 189.9%  
Current ratio x2.91.5 194.7%  
Inventory Days Days4233 126.3%  
Debtors Days Days1195 11.7%  
Net fixed assets Rs m19,25991,938 20.9%   
Share capital Rs m172909 18.9%   
"Free" reserves Rs m32,469119,006 27.3%   
Net worth Rs m32,640119,915 27.2%   
Long term debt Rs m161,419 1.2%   
Total assets Rs m43,807216,515 20.2%  
Interest coverage x90.2-8.6 -1,046.7%   
Debt to equity ratio x00 4.2%  
Sales to assets ratio x0.80.8 100.7%   
Return on assets %16.5-6.3 -261.4%  
Return on equity %21.8-12.6 -173.4%  
Return on capital %28.2-10.1 -277.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m18,67853,594 34.9%   
Fx outflow Rs m3,66238,143 9.6%   
Net fx Rs m15,01615,451 97.2%   
CASH FLOW
From Operations Rs m5,6203,673 153.0%  
From Investments Rs m-74112,922 -5.7%  
From Financial Activity Rs m-4,600-15,723 29.3%  
Net Cashflow Rs m279872 32.0%  

Share Holding

Indian Promoters % 66.1 46.8 141.2%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 25.9 43.4 59.7%  
FIIs % 10.1 14.0 72.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.9 52.9 64.1%  
Shareholders   59,798 360,677 16.6%  
Pledged promoter(s) holding % 19.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs Lupin Share Price Performance

Period AJANTA PHARMA Lupin S&P BSE HEALTHCARE
1-Day 2.61% 3.11% 1.20%
1-Month 3.05% 3.48% -3.18%
1-Year -13.70% -1.59% -7.59%
3-Year CAGR 9.47% 3.38% 16.43%
5-Year CAGR 5.48% -0.98% 9.40%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.1% stake in the company. In case of Lupin the stake stands at 47.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at -12.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15% Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15%(Closing)

After opening the day on a positive note, Indian share markets continued their momentum as the session progressed and ended higher.